ERG and PTEN Status of Isolated High Grade PIN Occurring in Cystoprostatectomy Specimens Without Invasive Prostatic Adenocarcinoma.

High grade prostatic intraepithelial neoplasia (HGPIN) is widely believed to represent a precursor to invasive prostatic adenocarcinoma. However, recent molecular studies have suggested that retrograde spread of invasive adenocarcinoma into pre-existing prostatic ducts can morphologically mimic HGPIN. Thus, previous molecular studies characterizing morphologically-identified HGPIN occurring in radical prostatectomies or needle biopsies with concurrent invasive carcinoma may be partially confounded by intraductal spread of invasive tumor. To assess ERG and PTEN status in HGPIN foci likely to represent true precursor lesions in the prostate, we studied isolated HGPIN occurring without associated invasive adenocarcinoma in cystoprostatectomies performed at Johns Hopkins between 2009 and 2014. Of 344 cystoprostatectomies, 33% (115/344) contained invasive prostatic adenocarcinoma in the partially submitted prostate (10 blocks/case on average) and were excluded from the study. Of the remaining cases without sampled cancer, 32% (73/229) showed 133 separate foci of HGPIN and were immunostained for ERG and PTEN using genetically validated protocols. Of foci of HGPIN with evaluable staining, 7% (8/107) were positive for ERG. PTEN loss was not seen in any HGPIN lesion (0/88). Because these isolated HGPIN foci at cystoprostatectomy are unlikely to represent retrograde spread of invasive tumor, our study suggests that ERG rearrangement, but not PTEN loss, is present in a minority of potential neoplastic precursor lesions in the prostate.

Human pathology. 2016 May 14 [Epub ahead of print]

Carlos L Morais, Liana B Guedes, Jessica Hicks, Alexander S Baras, Angelo M De Marzo, Tamara L Lotan

Pathology, Johns Hopkins School of Medicine, Baltimore, MD, United States., Pathology, Johns Hopkins School of Medicine, Baltimore, MD, United States., Pathology, Johns Hopkins School of Medicine, Baltimore, MD, United States., Pathology, Johns Hopkins School of Medicine, Baltimore, MD, United States., Pathology, Johns Hopkins School of Medicine, Baltimore, MD, United States; Urology, Johns Hopkins School of Medicine, Baltimore, MD, United States; Oncology, Johns Hopkins School of Medicine, Baltimore, MD, United States., Pathology, Johns Hopkins School of Medicine, Baltimore, MD, United States; Oncology, Johns Hopkins School of Medicine, Baltimore, MD, United States. Electronic address: .

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe